Cat. No. | Product name | CAS No. |
DCC4264 |
Protac_erralpha
Proteolysis targeting chimeras (PROTAC), providing broad tissue distribution and knockdown of the targeted ERRalpha protein in tumor xenografts |
|
DCC4265 |
Protac_ripk2
Proteolysis targeting chimeras (PROTAC), providing broad tissue distribution and knockdown of the targeted RIPK2 protein in tumor xenografts |
1801547-16-9 |
DCC4266 |
Protac-12
Novel SirReal-based PROTAC, inducing isotype-selective Sirt2 degradation, resulting in the hyperacetylation of the microtubule network coupled with enhanced process elongation |
|
DCC4267 |
Protac-3 (fak)
Novel selective and potent Fak degrader |
|
DCC4268 |
Protac-6c
The most potent and selective ERRα degrader |
|
DCC4269 |
Protac-i
Novel PROTAC, targeting steroid hormone receptors for ubiquitination and degradation |
1448189-04-5 |
DCC4270 |
Protegenin A
Novel bacterial polyyne contributing to the antioomycete and plant-protective effects of P. protegens |
|
DCC4271 |
Prs-211375
Novel selective CB2 agonist (CB2: 17.4 nM and CB1: 5585 nM) |
573981-31-4 |
DCC4272 |
Pr-snf
Novel potent and selective inhibitor of SETD2 |
|
DCC4273 |
Prucalopride Hydrochloride
Selective 5-HT4 agonist |
179474-80-7 |
DCC4274 |
Prx-07034
Novel selective 5-HT6 receptor antagonist, enhancing cognition and memory and potently decreasing food intake and body weight in rodents |
903580-39-2 |
DCC4275 |
Prx-08066 Maleate
Novel potent and selective 5-HT2B receptor antagonist |
866206-55-5 |
DCC4276 |
Ps1145 Dihydrochloride
Novel inhibitor of upstream IκB kinase (IKK), specifically inhibiting the IκB phosphorylation and degradation and the subsequent nuclear translocation of NF-κB |
1049743-58-9 |
DCC4277 |
Ps121912
Highly potent and selective VDR-coactivator inhibitor |
1529814-60-5 |
DCC4278 |
Psammaplysene B
Naturally occurring inhibitor of FOXO1a nuclear export |
865722-85-6 |
DCC4279 |
Psammaplysin F
Unique inhibitor of bacterial chromosomal partitioning, increasing the efficacy of bortezomib and sorafenib through regulation of stress granule formation |
|
DCC4280 |
Psb-1011
Potent competitive antagonist and positive modulator of the P2X2 receptor with >100-fold selectivity versus P2X4, P2X7, and several investigated P2Y receptor subtypes (P2Y(2,4,6,12)) |
4499-01-8 |
DCC4281 |
Psb-10129
Positive modulator of ATP effects at P2X2 receptors |
|
DCC4282 |
Psb-10211
Potent competitive antagonist and positive modulator of the P2X2 receptor |
66295-57-6 |
DCC4283 |
Psb-12105
Novel fluorescent-labeled selective adenosine A2B receptor antagonist |
|
DCC4284 |
Psb-1410
Highly potent, selective, competitive, and reversible inhibitor of monoamine oxidase B (MAO-B) |
1494477-03-0 |
DCC4285 |
Psb-1434
Featured
Highly potent, selective, competitive, and reversible inhibitor of monoamine oxidase B (MAO-B) |
1619884-65-9 |